In this video, Cathy covers the following medications: Factor Xa Inhibitors, Platelet Aggregation Inhibitors, and Thrombin inhibitors.
Specifically, i’ll be talking about a few more so let’s start off by talking about factor xa inhibitors. medications that fall within this class include rivaroxaban as well as apixaban, which is eliquis. so these medications are used to they work by selectively inhibiting factor xa, which helps to block the coagulation
Cascade. it looks like river. so if you take rivaroxaban, it will help your blood flow like a river big one to remember here. anytime we have an anticoagulant, bleeding is always going to be another side effect is possible elevated in addition, this class of medication carries a black box warning because if you
Abruptly discontinue to use this medication, it places the patient at higher risk for thrombotic events. so when your patient is on this medication, you want to monitor their liver function because of the risk of elevated liver enzymes. you’re also going to want to monitor their hemoglobin platelet aggregation
Inhibitors or antiplatelets. so the two medications that i’d be familiar with, that fall under this class, include clopidogrel and abciximab. so abciximab is the medication then so on which makes you wonder how they so these medications are used to prevent an mi they work by inhibiting platelet aggregation.
So when i think about the medication clopidogrel, it looks like clop. the first of part of it, so i think about a horse clopping on platelets and my little, silly way of remembering what bleeding is going to be a key side effect. hypotension tension as well as gi upset and rash are other side effects as well. so if your
Patient is on one of these medications, you’re also going to want to pay attention to your patient’s ekg and their vital signs because of alright, now let’s talk about thrombin inhibitors. include argatroban and dabigatran. these medications can be used to treat a dvt, a pe, they can help prevent a stroke, and
They are also used their mode of action is to block thrombin receptors which helps to prevent the activation of clotting factors and the formation of a clot. in addition, with argatroban, hypotension is a possible side effect, and with dabigatran, so the way i remember these medications and the key side effect of
Bleeding is i say, “there is no time to argue. you can’t just dab at the blood. you need to hold pressure to stop the bleeding from argatroban or dabigatran. so again, key side effect is bleeding and anytime your patient is so the key thing you’re going to be doing when a patient is on this therapy is assess
Other anticoagulants that we’ve talked about. okay. in my next video, we will be wrapping up our hematologic medications. we’ll be talking about a medication, and then we’ll also be covering erythropoiesis, growth factors, and leukopoietic growth factors as well. so hang in there with me!
Transcribed from video
Anticoagulants & Antiplatelets – Pharmacology (Pharm) – Cardiovascular – @Level Up RN By Level Up RN